Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
IV infusion remains a primary means of administering antineoplastic therapy. The presence of an IV access device and the administration of certain types of medication can result in complications. This course reviews risk factors, manifestations of complications, and prevention strategies for vascular access devices.
Learn about the process, risks, monitoring needs, and potential side effects of CAR T-cell therapy treatment of hematologic malignancies, with an emphasis on patient and family education. An interactive scenario and supporting resources reinforce learning.
New targeted therapies for Metastatic Colorectal Cancer have increased the need for awareness, education and training for nurses to prepare them to confidently manage and educate patients. This interactive activity will include a combination of learning strategies to build competencies in the area of diagnostic testing and treatment options.
New targeted therapies for Metastatic Colorectal Cancer have increased the need for awareness, education and training for nurses to prepare them to confidently manage and educate patients. This interactive activity will include a combination of learning strategies to build competencies and confidence in the area of side effect management.
What is normal cell biology? Why do normal cells become cancer cells? How do new molecular and targeted therapies target cancer? How do gene and vaccine therapies work? Find answers to these questions and more while gaining a better understanding of cancer and its treatments
A person with cancer will need vascular access of some type if they will be receiving IV treatment.
These oral chemotherapy patient education sheets are a tool to educate patients and caregivers about oral chemotherapy drugs and their side effects.
Cancer care across the healthcare continuum has been revolutionized by advances in the understanding and application of genomics. The paradigm shift to biomarker-driven treatment decisions is a large step toward achieving precision oncology, which is the use of tumor-specific information, like genomic information, to inform cancer care.